Status:
ACTIVE_NOT_RECRUITING
Exercise Endothelial Progenitor Cells (EPCs) and Type 2 Diabetes
Lead Sponsor:
Baltimore VA Medical Center
Collaborating Sponsors:
University of Maryland, Baltimore
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
50-80 years
Phase:
NA
Brief Summary
The discovery of the role of endothelial progenitor cells (EPCs) and their involvement in the cardiovascular complications of type 2 diabetes (T2DM) would quickly have a significant impact on the mill...
Eligibility Criteria
Inclusion
- Age 50-80
- Non-smoker
- If woman, postmenopausal \>1 year
Exclusion
- History of heart disease or stroke
- Cancer
- Poorly controlled hypertension or dyslipidemia
- Kidney or Liver diseases
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT01176578
Start Date
July 1 2011
End Date
December 31 2026
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baltimore VA Medical Center
Baltimore, Maryland, United States, 21201